Cost-Benefit Analysis of Sumatriptan Tablets versus Usual Therapy for Treatment of Migraine
- 1 November 2000
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 20 (11) , 1356-1364
- https://doi.org/10.1592/phco.20.17.1356.34890
Abstract
We performed a systematic assessment of the costs and benefits of sumatriptan and usual therapy for migraine from society's perspective. A decision tree was constructed with probability estimates bas...Keywords
This publication has 19 references indexed in Scilit:
- Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?Headache: The Journal of Head and Face Pain, 1999
- Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient StudyHeadache: The Journal of Head and Face Pain, 1998
- The Long‐term Tolerability and Efficacy of Oral Zolmitriptan (Zomig, 31X90) in the Acute Treatment of Migraine. An International StudyHeadache: The Journal of Head and Face Pain, 1998
- A Multinational Investigation of the Impact of Subcutaneous SumatriptanPharmacoEconomics, 1997
- Comparing Dihydroergotamine Mesylate and Sumatriptan in the Management of Acute MigrainePharmacoEconomics, 1996
- Impact of Sumatriptan on Workplace Productivity, Nonwork Activities, and Health‐Related Quality of Life Among Hospital Employees With MigraineHeadache: The Journal of Head and Face Pain, 1996
- Quality-of-Life Assessment in Patients With HeadachePharmacoEconomics, 1994
- The Willingness to Pay for In Vitro Fertilization: A Pilot Study Using Contingent ValuationMedical Care, 1994
- Healthcare Resource and Lost Labour Costs of Migraine Headache in the USPharmacoEconomics, 1992
- Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factorsPublished by American Medical Association (AMA) ,1992